The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models

Leila Takahashi‐Ruiz(The University of Texas at San Antonio Health Science Center), April L. Risinger(The University of Texas at San Antonio Health Science Center)
Cancers
December 2, 2022
Cited by 31


Related Papers